UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (3), p.342-349

2012

Volltextzugriff (PDF)

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Journal of cutaneous medicine and surgery, 2019-01, Vol.23 (1), p.50-74

2019

Volltextzugriff (PDF)

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Gut, 2023-08, Vol.72 (8), p.1462-1471

2023

Volltextzugriff (PDF)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity

JGH open, 2018-10, Vol.2 (5), p.201-206

2018

Volltextzugriff (PDF)

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.1-13

2019

Volltextzugriff (PDF)

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Journal of rheumatology, 2019-07, Vol.46 (7), p.751-754

2019

Volltextzugriff (PDF)

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2803-2812

2021

Volltextzugriff (PDF)

Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis

Inflammatory bowel diseases, 2011-09, Vol.17 (9), p.1936-1942

2011

Volltextzugriff (PDF)

Stricturing and Fistulizing Crohn’s Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease

Digestive diseases and sciences, 2018-09, Vol.63 (9), p.2430-2438

2018

Volltextzugriff (PDF)

Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality

Inflammatory bowel diseases, 2008-12, Vol.14 (12), p.1688-1694

2008

Volltextzugriff (PDF)

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.639-644

2011

Volltextzugriff (PDF)

Impact of gastroenterologist care on health outcomes of hospitalised ulcerative colitis patients

Gut, 2012-10, Vol.61 (10), p.1410-1416

2012

Volltextzugriff (PDF)

Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease

Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00401

2021

Volltextzugriff (PDF)

Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

Inflammatory bowel diseases, 2006-10, Vol.12 (10), p.979-994

2006

Volltextzugriff (PDF)

Serum antibodies associated with complex inflammatory bowel disease

Inflammatory bowel diseases, 2013-06, Vol.19 (7), p.1499-1505

2013

Volltextzugriff (PDF)

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2018-07, Vol.24 (8), p.1808-1814

2018

Volltextzugriff (PDF)

Associations between quantitative evaluation of bowel wall microvascular flow by contrast‐enhanced ultrasound and indices of disease activity in Crohn's disease patients using both bolus and infusion techniques

Journal of clinical ultrasound, 2019-10, Vol.47 (8), p.453-460

2019

Volltextzugriff (PDF)

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Inflammatory bowel diseases, 2018-03, Vol.24 (4), p.669-670

Steinhart, A Hillary

2018

Volltextzugriff (PDF)

Risk factors for low bone density in Crohn's disease

Inflammatory bowel diseases, 2002-03, Vol.8 (2), p.87-92

2002

Volltextzugriff (PDF)

Traditional corticosteroids for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2008-04 (2), p.CD006792

2008

Volltextzugriff (PDF)

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease

Inflammatory bowel diseases, 2016-03, Vol.22 (3), p.623-630

2016

Volltextzugriff (PDF)

Clinical guidelines for the medical management of left‐sided ulcerative colitis and ulcerative proctitis: Summary statement

Inflammatory bowel diseases, 2006-10, Vol.12 (10), p.972-978

2006

Volltextzugriff (PDF)

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011

Inflammatory bowel diseases, 2017-06, Vol.23 (6), p.868-874

2017

Volltextzugriff (PDF)

Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists

Inflammatory bowel diseases, 2017-07, Vol.23 (7), p.1168-1173

2017

Volltextzugriff (PDF)

Choosing Therapies in Ulcerative Colitis

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (1), p.9-21

2024

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Englisch
(172)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(78)
Humans
(71)
Gastroenterology & Hepatology
(62)
Inflammatory Bowel Disease
(51)
Crohn's Disease
(36)
Adult
(35)
Female
(35)
Male
(35)
Ulcerative Colitis
(34)
Middle Aged
(24)
Gastroenterology
(22)
Young Adult
(19)
Inflammatory Bowel Diseases
(17)
Crohn Disease - Drug Therapy
(16)
General & Internal Medicine
(15)
Medicine, General & Internal
(15)
Colitis, Ulcerative - Drug Therapy
(13)
Randomized Controlled Trials As Topic
(13)
Remission Induction
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis

Stricturing and Fistulizing Crohn’s Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease

Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Impact of gastroenterologist care on health outcomes of hospitalised ulcerative colitis patients

Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease

Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

Serum antibodies associated with complex inflammatory bowel disease

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Associations between quantitative evaluation of bowel wall microvascular flow by contrast‐enhanced ultrasound and indices of disease activity in Crohn's disease patients using both bolus and infusion techniques

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Risk factors for low bone density in Crohn's disease

Traditional corticosteroids for induction of remission in Crohn's disease

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease

Clinical guidelines for the medical management of left‐sided ulcerative colitis and ulcerative proctitis: Summary statement

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011

Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists

Choosing Therapies in Ulcerative Colitis

Aktive Filter

Suchergebnisse filtern